Today, Slone Partners celebrates 26 years. Thank you to our clients, candidates, and colleagues who have been part of our journey!

This #BreastCancerAwarenessMonth, we stand with patients, survivors, families & caregivers and salute the researchers, clinicians & advocates working to advance earlier detection, better treatments, & improved outcomes. #BreastCancerAwareness

What are the primary factors driving retirement decisions in biopharma? Our CEO|Managing Partner Leslie Loveless shares her thoughts in this article in @BioSpace. Among her insights–many delay retirement because they want to continue making an impact. tinyurl.com/hn8m7ssc

Today, we remember September 11, 2001. Twenty-five years later, we honor the lives lost, the families forever changed, and the courage of the first responders and countless individuals who stepped forward in the face of unimaginable tragedy. #NeverForget #September11

This month, we raise awareness, challenge stigmas, & support the millions affected by Alzheimer’s, including their families & caregivers. We also recognize the researchers, clinicians, scientists, & leaders advancing new diagnoses, treatments, & improving quality of life.

Slone Partners delivers visionary leaders and fractional talent for dynamic organizations in life sciences and healthcare. Learn more at slonepartners.com

Slone Partners is proud to announce the placement of Farhad Ghavami as Chief Executive Officer at @SeqCenter ! Read the full press release here: slonepartners.com/slone-part…

We are proud to announce the appointments of Sona Stroud M.Ed. and Kim Wilson as Senior Partners at Slone Partners. 🎉 Read the full announcement: slonepartners.com/slone-part…

Dynamic #Healthcare organizations driving innovation need visionary leaders with determination, ethics, & heart. We align with your needs to deliver transformative talent who push the boundaries of possibility. Learn more about how we can work together: bit.ly/3Ng7xtN

Slone Partners is pleased to announce the placement of Amer Mirza, PhD, as Chief Scientific Officer (CSO) at Prolynx. Read the full press release here: slonepartners.com/slone-part…

De-risking the executive recruiting & hiring process requires an intentional & strategic approach that defines the success profile, produces a broad candidate pool, & allows for structured integration. Read more in our new blog. slonepartners.com/how-to-de-…

It’s fascinating to track the rapid advances in precision medicine as it redefines healthcare by moving beyond one-size-fits-all treatments to therapies specifically tailored to each patient's unique genetic, environmental, & lifestyle profile. tinyurl.com/mvtm5snr

Great news! June saw a surge of investment activity, boosting the number of $100M raises to 40 for the first half of the year. Stronger financing reflects renewed confidence in companies working across a range of therapeutic areas. tinyurl.com/v8d8xt7h

In today’s unpredictable business climate, companies need flexibility to stay competitive. Our Fractional Talent service provides you access to proven leaders & functional specialists to fill part-time, interim, or project-based roles. Learn more: bit.ly/4keZhHY

The life sciences IPO market continues to show signs of recovery. As the @BosBizJournal reports, a growing number of Massachusetts biotech companies are successfully entering the public markets – a positive signal for investor confidence. tinyurl.com/bd2ty5up

The convergence of machine learning, precision medicine, & pharmacogenomics is opening an exciting new chapter in healthcare by helping researchers better understand how an individual’s genetic makeup influences their response to different therapies. tinyurl.com/585s6v29

You want visionary leaders who push the boundaries of possibilities in a dynamic industry, so you turn to us for our industry knowledge, extensive talent network, & extraordinary track record. Learn how we can be your complete search partner: bit.ly/3Y0Yj7W

As #lifesciences IPO & investment activities rise, we may start to see a commensurate rise in leadership positions, both full-time & fractional. Our CEO|Managing Partner Leslie Loveless offers her perspectives on the topic in @PharmaVoice. tinyurl.com/bdemhxm4

People Are Our Science® slonepartners.com

Congratulations to the team at Parabilis Medicines for achieving the biggest Nasdaq debut the biopharma industry has ever seen! This record-breaking IPO highlights continued investor confidence in innovative science & transforming patient care. tinyurl.com/2ybbrzb7